deferoxamine has been researched along with cilostazol in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Kim, K; Kim, KM; Lee, MS; Park, SE; Park, YC | 1 |
1 review(s) available for deferoxamine and cilostazol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for deferoxamine and cilostazol
Article | Year |
---|---|
Induction of heme oxygenase‑1 expression protects articular chondrocytes against cilostazol‑induced cellular senescence.
Topics: Animals; beta Catenin; beta-Galactosidase; Cell Survival; Cellular Senescence; Chondrocytes; Cilostazol; Collagen Type II; Deferoxamine; Female; Heme Oxygenase (Decyclizing); Molsidomine; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; RNA, Small Interfering; Tetrazoles; Up-Regulation | 2014 |